$EBS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Emergent BioSolutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Emergent BioSolutions Inc.. Get notifications about new insider transactions in Emergent BioSolutions Inc. for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 21 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 18 2013 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Grant | A | 0.00 | 5,400 | 0 | 5,400 | 0 to 5.4 K |
Jun 04 2013 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | J | 0.00 | 347,488 | 0 | 2,090,157 | 1.7 M to 2.1 M (+19.94 %) |
Jun 04 2013 | EBS | Emergent BioSoluti ... | Kramer Robert | CFO | Buy | J | 0.00 | 58,249 | 0 | 87,560 | 29.3 K to 87.6 K (+198.73 %) |
Jun 04 2013 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Buy | P | 12.07 | 800 | 9,656 | 96,011 | 95.2 K to 96 K (+0.84 %) |
May 24 2013 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Option Exercise | A | 14.25 | 7,200 | 102,600 | 7,200 | |
May 24 2013 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Grant | A | 0.00 | 3,600 | 0 | 16,200 | 12.6 K to 16.2 K (+28.57 %) |
May 24 2013 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | A | 14.25 | 7,200 | 102,600 | 7,200 | |
May 24 2013 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Grant | A | 0.00 | 3,600 | 0 | 14,400 | 10.8 K to 14.4 K (+33.33 %) |
May 24 2013 | EBS | Emergent BioSoluti ... | Niederhuber John | Director | Option Exercise | A | 14.25 | 7,200 | 102,600 | 7,200 | |
May 24 2013 | EBS | Emergent BioSoluti ... | Niederhuber John | Director | Grant | A | 0.00 | 3,600 | 0 | 16,200 | 12.6 K to 16.2 K (+28.57 %) |
May 24 2013 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 14.25 | 7,200 | 102,600 | 7,200 | |
May 24 2013 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 3,600 | 0 | 14,400 | 10.8 K to 14.4 K (+33.33 %) |
May 24 2013 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Option Exercise | A | 14.25 | 7,200 | 102,600 | 7,200 | |
May 24 2013 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Grant | A | 0.00 | 3,600 | 0 | 14,400 | 10.8 K to 14.4 K (+33.33 %) |
May 24 2013 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | A | 14.25 | 7,200 | 102,600 | 7,200 | |
May 24 2013 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Grant | A | 0.00 | 3,600 | 0 | 14,400 | 10.8 K to 14.4 K (+33.33 %) |
Apr 19 2013 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 15.05 | 62,851 | 945,606 | 1,742,669 | 1.8 M to 1.7 M (-3.48 %) |
Apr 19 2013 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 15.02 | 52,021 | 781,335 | 1,805,520 | 1.9 M to 1.8 M (-2.80 %) |
Mar 18 2013 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 14.46 | 4,294 | 62,091 | 1,856,053 | 1.9 M to 1.9 M (-0.23 %) |
Mar 18 2013 | EBS | Emergent BioSoluti ... | Chatfield Steven | EVP, BioSciences | Payment of Exercise | F | 14.46 | 1,008 | 14,576 | 28,000 | 29 K to 28 K (-3.47 %) |
Mar 18 2013 | EBS | Emergent BioSoluti ... | Havey Adam | SVP, Biodefense Div ... | Payment of Exercise | F | 14.46 | 1,046 | 15,125 | 36,823 | 37.9 K to 36.8 K (-2.76 %) |
Mar 18 2013 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO & President | Payment of Exercise | F | 14.46 | 2,248 | 32,506 | 95,211 | 97.5 K to 95.2 K (-2.31 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 14.67 | 41,804 | 613,265 | 41,804 | |
Mar 12 2013 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Grant | A | 0.00 | 20,902 | 0 | 1,860,347 | 1.8 M to 1.9 M (+1.14 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 14.67 | 1,717 | 25,188 | 1,839,445 | 1.8 M to 1.8 M (-0.09 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 15.22 | 4,408 | 67,090 | 1,841,162 | 1.8 M to 1.8 M (-0.24 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Havey Adam | SVP, Biodefense Div ... | Option Exercise | A | 14.67 | 23,879 | 350,305 | 23,879 | |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Havey Adam | SVP, Biodefense Div ... | Grant | A | 0.00 | 11,939 | 0 | 31,077 | 19.1 K to 31.1 K (+62.38 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Havey Adam | SVP, Biodefense Div ... | Payment of Exercise | F | 14.67 | 820 | 12,029 | 19,138 | 20 K to 19.1 K (-4.11 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Havey Adam | SVP, Biodefense Div ... | Payment of Exercise | F | 15.22 | 642 | 9,771 | 19,958 | 20.6 K to 20 K (-3.12 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Chatfield Steven | EVP, BioSciences | Option Exercise | A | 14.67 | 23,879 | 350,305 | 23,879 | |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Chatfield Steven | EVP, BioSciences | Grant | A | 0.00 | 11,939 | 0 | 29,008 | 17.1 K to 29 K (+69.95 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Chatfield Steven | EVP, BioSciences | Payment of Exercise | F | 14.67 | 1,833 | 26,890 | 17,069 | 18.9 K to 17.1 K (-9.70 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Chatfield Steven | EVP, BioSciences | Payment of Exercise | F | 15.22 | 1,434 | 21,825 | 18,902 | 20.3 K to 18.9 K (-7.05 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO & President | Option Exercise | A | 14.67 | 81,669 | 1,198,084 | 81,669 | |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO & President | Grant | A | 0.00 | 40,834 | 0 | 97,459 | 56.6 K to 97.5 K (+72.11 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO & President | Payment of Exercise | F | 14.67 | 3,201 | 46,959 | 56,625 | 59.8 K to 56.6 K (-5.35 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO & President | Payment of Exercise | F | 15.22 | 2,304 | 35,067 | 59,826 | 62.1 K to 59.8 K (-3.71 %) |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Kramer Robert | Chief Financial Off ... | Option Exercise | A | 14.67 | 7,879 | 115,585 | 7,879 | |
Mar 12 2013 | EBS | Emergent BioSoluti ... | Kramer Robert | Chief Financial Off ... | Grant | A | 0.00 | 3,940 | 0 | 29,311 | 25.4 K to 29.3 K (+15.53 %) |
Jan 18 2013 | EBS | Emergent BioSoluti ... | Kramer Robert | CFO | Option Exercise | A | 14.41 | 23,062 | 332,323 | 23,062 | |
Jan 18 2013 | EBS | Emergent BioSoluti ... | Kramer Robert | CFO | Grant | A | 0.00 | 11,531 | 0 | 25,371 | 13.8 K to 25.4 K (+83.32 %) |
Dec 28 2012 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO & President | Option Exercise | M | 10.13 | 7,300 | 73,949 | 4,613 | |
Dec 28 2012 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO & President | Payment of Exercise | F | 15.81 | 4,677 | 73,943 | 62,148 | 66.8 K to 62.1 K (-7.00 %) |
Dec 28 2012 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO & President | Buy | M | 10.13 | 7,300 | 73,949 | 66,825 | 59.5 K to 66.8 K (+12.26 %) |
Dec 14 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Gift | G | 0.00 | 149,712 | 0 | 149,712 | 0 to 149.7 K |
Dec 14 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Gift | G | 0.00 | 13,333 | 0 | 13,333 | 0 to 13.3 K |
Dec 14 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Gift | G | 0.00 | 13,333 | 0 | 13,333 | 0 to 13.3 K |
Dec 14 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Gift | G | 0.00 | 176,378 | 0 | 127,721 | 304.1 K to 127.7 K (-58.00 %) |
Dec 14 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Gift | G | 0.00 | 224,628 | 0 | 224,628 | 0 to 224.6 K |
Dec 14 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Gift | G | 0.00 | 304,098 | 0 | 304,098 | 0 to 304.1 K |
Dec 06 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 15.08 | 43,064 | 649,539 | 1,845,570 | 1.9 M to 1.8 M (-2.28 %) |
Dec 03 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 15.02 | 22,875 | 343,576 | 1,888,634 | 1.9 M to 1.9 M (-1.20 %) |
Dec 03 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 15.21 | 34,061 | 518,224 | 1,911,509 | 1.9 M to 1.9 M (-1.75 %) |
Oct 05 2012 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP Corporate Svs. ... | Payment of Exercise | F | 14.79 | 290 | 4,289 | 13,840 | 14.1 K to 13.8 K (-2.05 %) |
Sep 20 2012 | EBS | Emergent BioSoluti ... | Intervac, L.L.C. | 10% Owner | Sell | J | 0.00 | 150,000 | 0 | 4,344,250 | 4.5 M to 4.3 M (-3.34 %) |
Sep 20 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | J | 0.00 | 150,000 | 0 | 1,945,570 | 1.8 M to 1.9 M (+8.35 %) |
Sep 20 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | J | 0.00 | 150,000 | 0 | 4,344,250 | 4.5 M to 4.3 M (-3.34 %) |
Sep 10 2012 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP Corporate Svs. ... | Sell | S | 14.82 | 28,000 | 414,960 | 14,130 | 42.1 K to 14.1 K (-66.46 %) |
Sep 04 2012 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP Corporate Svcs. ... | Payment of Exercise | F | 14.79 | 5,870 | 86,817 | 42,130 | 48 K to 42.1 K (-12.23 %) |
Aug 14 2012 | EBS | Emergent BioSoluti ... | Kramer Robert | consultant | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Jun 06 2012 | EBS | Emergent BioSoluti ... | Intervac, L.L.C. | 10% Owner | Sell | J | 0.00 | 33,702 | 0 | 4,494,250 | 4.5 M to 4.5 M (-0.74 %) |
Jun 06 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | J | 0.00 | 33,702 | 0 | 4,494,250 | 4.5 M to 4.5 M (-0.74 %) |
May 21 2012 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Option Exercise | A | 14.66 | 7,200 | 105,552 | 7,200 | |
May 21 2012 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Grant | A | 0.00 | 3,600 | 0 | 12,600 | 9 K to 12.6 K (+40.00 %) |
May 21 2012 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | A | 14.66 | 7,200 | 105,552 | 7,200 | |
May 21 2012 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Grant | A | 0.00 | 3,600 | 0 | 10,800 | 7.2 K to 10.8 K (+50.00 %) |
May 21 2012 | EBS | Emergent BioSoluti ... | Niederhuber John | Director | Option Exercise | A | 14.66 | 7,200 | 105,552 | 7,200 | |
May 21 2012 | EBS | Emergent BioSoluti ... | Niederhuber John | Director | Grant | A | 0.00 | 3,600 | 0 | 12,600 | 9 K to 12.6 K (+40.00 %) |
May 21 2012 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Option Exercise | A | 14.66 | 7,200 | 105,552 | 7,200 | |
May 21 2012 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Grant | A | 0.00 | 3,600 | 0 | 10,800 | 7.2 K to 10.8 K (+50.00 %) |
May 21 2012 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 14.66 | 7,200 | 105,552 | 7,200 | |
May 21 2012 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 3,600 | 0 | 10,800 | 7.2 K to 10.8 K (+50.00 %) |
May 21 2012 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | A | 14.66 | 7,200 | 105,552 | 7,200 | |
May 21 2012 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Grant | A | 0.00 | 3,600 | 0 | 10,800 | 7.2 K to 10.8 K (+50.00 %) |
May 17 2012 | EBS | Emergent BioSoluti ... | Intervac, L.L.C. | 10% Owner | Sell | J | 0.00 | 191,950 | 0 | 4,527,952 | 4.7 M to 4.5 M (-4.07 %) |
May 17 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | J | 0.00 | 191,950 | 0 | 4,527,952 | 4.7 M to 4.5 M (-4.07 %) |
May 17 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | J | 0.00 | 281,190 | 0 | 1,795,570 | 1.5 M to 1.8 M (+18.57 %) |
May 09 2012 | EBS | Emergent BioSoluti ... | Intervac, L.L.C. | 10% Owner | Sell | J | 0.00 | 779,951 | 0 | 4,719,902 | 5.5 M to 4.7 M (-14.18 %) |
May 09 2012 | EBS | Emergent BioSoluti ... | Intervac, L.L.C. | 10% Owner | Sell | J | 0.00 | 45,647 | 0 | 5,499,853 | 5.5 M to 5.5 M (-0.82 %) |
May 09 2012 | EBS | Emergent BioSoluti ... | Intervac, L.L.C. | 10% Owner | Sell | J | 0.00 | 45,647 | 0 | 5,545,500 | 5.6 M to 5.5 M (-0.82 %) |
May 09 2012 | EBS | Emergent BioSoluti ... | Intervac, L.L.C. | 10% Owner | Sell | J | 0.00 | 45,647 | 0 | 5,591,147 | 5.6 M to 5.6 M (-0.81 %) |
May 09 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | J | 0.00 | 779,951 | 0 | 4,719,902 | 5.5 M to 4.7 M (-14.18 %) |
May 09 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | J | 0.00 | 45,647 | 0 | 5,499,853 | 5.5 M to 5.5 M (-0.82 %) |
May 09 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | J | 0.00 | 45,647 | 0 | 5,545,500 | 5.6 M to 5.5 M (-0.82 %) |
May 09 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | J | 0.00 | 45,647 | 0 | 5,591,147 | 5.6 M to 5.6 M (-0.81 %) |
Mar 16 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | CEO & Chairman | Option Exercise | A | 15.83 | 32,100 | 508,143 | 32,100 | |
Mar 16 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | CEO & Chairman | Payment of Exercise | F | 16.05 | 3,538 | 56,785 | 1,514,380 | 1.5 M to 1.5 M (-0.23 %) |
Mar 16 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | CEO & Chairman | Grant | A | 0.00 | 16,050 | 0 | 1,517,918 | 1.5 M to 1.5 M (+1.07 %) |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Elsey R Don | Chief Financial Off ... | Option Exercise | A | 15.83 | 12,300 | 194,709 | 12,300 | |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Elsey R Don | Chief Financial Off ... | Payment of Exercise | F | 16.05 | 765 | 12,278 | 26,614 | 27.4 K to 26.6 K (-2.79 %) |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Elsey R Don | Chief Financial Off ... | Grant | A | 0.00 | 6,150 | 0 | 27,379 | 21.2 K to 27.4 K (+28.97 %) |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Havey Adam | SVP, Biodefense Div ... | Option Exercise | A | 15.83 | 14,700 | 232,701 | 14,700 | |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Havey Adam | SVP, Biodefense Div ... | Payment of Exercise | F | 16.05 | 1,049 | 16,836 | 27,970 | 29 K to 28 K (-3.61 %) |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Havey Adam | SVP, Biodefense Div ... | Grant | A | 0.00 | 7,350 | 0 | 29,019 | 21.7 K to 29 K (+33.92 %) |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Chatfield Steven | EVP and President, ... | Option Exercise | A | 15.83 | 22,000 | 348,260 | 22,000 | |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Chatfield Steven | EVP and President, ... | Payment of Exercise | F | 16.05 | 1,009 | 16,194 | 20,341 | 21.4 K to 20.3 K (-4.73 %) |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Chatfield Steven | EVP and President, ... | Grant | A | 0.00 | 11,000 | 0 | 22,783 | 11.8 K to 22.8 K (+93.35 %) |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Chatfield Steven | EVP and President, ... | Payment of Exercise | F | 14.49 | 1,433 | 20,764 | 10,350 | 11.8 K to 10.4 K (-12.16 %) |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Option Exercise | A | 15.83 | 56,500 | 894,395 | 56,500 | |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Payment of Exercise | F | 16.05 | 2,185 | 35,069 | 59,525 | 61.7 K to 59.5 K (-3.54 %) |
Mar 16 2012 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Grant | A | 0.00 | 28,250 | 0 | 61,710 | 33.5 K to 61.7 K (+84.43 %) |
Mar 12 2012 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | CEO & Chairman | Payment of Exercise | F | 14.49 | 3,730 | 54,048 | 1,501,868 | 1.5 M to 1.5 M (-0.25 %) |
Mar 12 2012 | EBS | Emergent BioSoluti ... | Havey Adam | SVP, Biodefense Div ... | Payment of Exercise | F | 14.49 | 535 | 7,752 | 14,319 | 14.9 K to 14.3 K (-3.60 %) |
Mar 12 2012 | EBS | Emergent BioSoluti ... | Elsey R Don | Chief Financial Off ... | Payment of Exercise | F | 14.49 | 970 | 14,055 | 21,229 | 22.2 K to 21.2 K (-4.37 %) |
Mar 12 2012 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Payment of Exercise | F | 14.49 | 2,303 | 33,370 | 33,460 | 35.8 K to 33.5 K (-6.44 %) |
Jul 29 2011 | EBS | Emergent BioSoluti ... | Intervac, L.L.C. | 10% Owner | Sell | J | 0.00 | 500,000 | 0 | 5,636,794 | 6.1 M to 5.6 M (-8.15 %) |
Jul 29 2011 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | CEO & Chairman | Buy | J | 0.00 | 5,417 | 0 | 15,845 | 10.4 K to 15.8 K (+51.95 %) |
Jul 29 2011 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | CEO & Chairman | Buy | J | 0.00 | 5,417 | 0 | 15,845 | 10.4 K to 15.8 K (+51.95 %) |
Jul 29 2011 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | CEO & Chairman | Buy | J | 0.00 | 5,417 | 0 | 15,845 | 10.4 K to 15.8 K (+51.95 %) |
Jul 29 2011 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | CEO & Chairman | Buy | J | 0.00 | 205,535 | 0 | 1,505,598 | 1.3 M to 1.5 M (+15.81 %) |
Jun 09 2011 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Option Exercise | M | 11.67 | 4,800 | 56,016 | 0 | |
Jun 09 2011 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Option Exercise | M | 8.76 | 4,800 | 42,048 | 0 | |
Jun 09 2011 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Sell | S | 24.00 | 4,800 | 115,200 | 7,200 | 12 K to 7.2 K (-40.00 %) |
Jun 09 2011 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Buy | M | 11.67 | 4,800 | 56,016 | 12,000 | 7.2 K to 12 K (+66.67 %) |
Jun 09 2011 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Sell | S | 24.00 | 4,800 | 115,200 | 7,200 | 12 K to 7.2 K (-40.00 %) |
Jun 09 2011 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Buy | M | 8.76 | 4,800 | 42,048 | 12,000 | 7.2 K to 12 K (+66.67 %) |
Jun 08 2011 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Option Exercise | M | 8.43 | 19,698 | 166,054 | 0 | |
Jun 08 2011 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Option Exercise | M | 8.43 | 1,902 | 16,034 | 19,698 | |
Jun 08 2011 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Sell | S | 24.01 | 19,698 | 472,949 | 7,200 | 26.9 K to 7.2 K (-73.23 %) |
Jun 08 2011 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Buy | M | 8.43 | 19,698 | 166,054 | 26,898 | 7.2 K to 26.9 K (+273.58 %) |
Jun 08 2011 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Sell | S | 23.50 | 1,902 | 44,697 | 7,200 | 9.1 K to 7.2 K (-20.90 %) |
Jun 08 2011 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Buy | M | 8.43 | 1,902 | 16,034 | 9,102 | 7.2 K to 9.1 K (+26.42 %) |
May 27 2011 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | CEO & Chairman | Sell | S | 26.03 | 27,900 | 726,209 | 1,300,063 | 1.3 M to 1.3 M (-2.10 %) |
May 27 2011 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | CEO & Chairman | Sell | S | 25.53 | 50,000 | 1,276,670 | 1,327,963 | 1.4 M to 1.3 M (-3.63 %) |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Option Exercise | M | 8.43 | 13,361 | 112,633 | 0 | |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Option Exercise | M | 13.42 | 30,000 | 402,600 | 0 | |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Option Exercise | M | 10.13 | 30,087 | 304,781 | 11,913 | |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Option Exercise | M | 7.00 | 25,000 | 175,000 | 0 | |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Option Exercise | M | 7.00 | 75,000 | 525,000 | 0 | |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Sell | S | 23.99 | 5,067 | 121,557 | 35,763 | 40.8 K to 35.8 K (-12.41 %) |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Sell | S | 24.18 | 13,361 | 323,069 | 40,830 | 54.2 K to 40.8 K (-24.66 %) |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Buy | M | 8.43 | 13,361 | 112,633 | 54,191 | 40.8 K to 54.2 K (+32.72 %) |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Sell | S | 24.18 | 30,000 | 725,400 | 40,830 | 70.8 K to 40.8 K (-42.35 %) |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Buy | M | 13.42 | 30,000 | 402,600 | 70,830 | 40.8 K to 70.8 K (+73.48 %) |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Sell | S | 24.18 | 30,087 | 727,504 | 40,830 | 70.9 K to 40.8 K (-42.43 %) |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Buy | M | 10.13 | 30,087 | 304,781 | 10,743 | -19,344 to 10.7 K (-155.54 %) |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Sell | S | 24.91 | 25,000 | 622,750 | 40,830 | 65.8 K to 40.8 K (-37.98 %) |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Buy | M | 8.43 | 25,000 | 210,750 | 65,830 | 40.8 K to 65.8 K (+61.23 %) |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Sell | S | 24.91 | 75,000 | 1,868,250 | 40,830 | 115.8 K to 40.8 K (-64.75 %) |
Jun 02 2011 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & COO | Buy | M | 7.00 | 75,000 | 525,000 | 115,830 | 40.8 K to 115.8 K (+183.69 %) |
May 24 2011 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | CEO & Chairman | Buy | J | 0.00 | 281,190 | 0 | 1,377,963 | 1.1 M to 1.4 M (+25.64 %) |
May 23 2011 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 22.02 | 7,200 | 158,544 | 7,200 | |
May 23 2011 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 3,600 | 0 | 7,200 | 3.6 K to 7.2 K (+100.00 %) |
May 23 2011 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Option Exercise | A | 22.02 | 7,200 | 158,544 | 7,200 | |
May 23 2011 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Grant | A | 0.00 | 3,600 | 0 | 9,000 | 5.4 K to 9 K (+66.67 %) |
May 23 2011 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | A | 22.02 | 7,200 | 158,544 | 7,200 | |
May 23 2011 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Grant | A | 0.00 | 3,600 | 0 | 7,200 | 3.6 K to 7.2 K (+100.00 %) |
May 23 2011 | EBS | Emergent BioSoluti ... | Niederhuber John | Director | Option Exercise | A | 22.02 | 7,200 | 158,544 | 7,200 | |
May 23 2011 | EBS | Emergent BioSoluti ... | Niederhuber John | Director | Grant | A | 0.00 | 3,600 | 0 | 9,000 | 5.4 K to 9 K (+66.67 %) |